SBIO
Fund Stats as of 11/17/2017
Symbol SBIO
CUSIP 00162Q 593
ISIN US00162Q5936
Inception Date 12/30/2014
Dividends Paid Annual
Fund Type Exchange Traded Fund
Market Price $30.59
Last Trade Price $30.66
NAV $30.62
NAV Change $0.17
Total Net Assets $124,011,322
Total Market Value $124,026,107
Premium/Discount(%) -0.10%
Difference ($) $-0.03
Volume 10,854
Shares Outstanding 4,050,000
Expenses as of 03/31/2017
Management Fee0.50%
Other Expenses0.00%
Total Operating Expenses0.50%
Fund Resources
Summary Prospectus 
Statement of Additional Information 
Quarterly Fact Sheet 
Statutory Prospectus 
Resource Library  

Index Characteristics as of 09/30/2017, subject to change

Index Top Ten Holdings

Index Name % of Index
Bluebird Bio Inc 4.71%
Exelixis Inc 4.22%
Galapagos Nv-Spon Adr 3.89%
Acadia Pharmaceuticals I 3.47%
Taro Pharmaceutical Indu 3.44%
Beigene Ltd-Adr 3.30%
Fibrogen Inc 3.21%
Akorn Inc 3.12%
Opko Health Inc 2.89%
Nektar Therapeutics 2.82%

PMBI Drug Development Pipeline

Pre-Clinical 308
Phase I 324
Phase II 401
Phase III 156
Regulatory Filing for Approval 43
Other 12

Index Profile

Index Description Value
Number of Companies 90
Market Capitalization ($ Agg. Millions) $136,146
Company Size ($ Millions)
   Average $2,889
   Median $838
   Largest $7,121
   Smallest $87
% Weight Largest Company 4.71%
Top 10 Holdings (% Market Cap Share) 35.07%
Correlation with S&P 500® Index 0.55